• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Procollagen C-endopeptidase enhancer 2 (PCOLCE2)

ACP18848

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP18848 Target NamePCOLCE2
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range24-415Protein LengthFull Length of Mature Protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9UKZ9
Background Information
  • Uniprot Id

    Q9UKZ9

  • Target Species

    Human

  • Target Name

    PCOLCE2

  • Target Full Name

    Procollagen C-endopeptidase enhancer 2

  • Target Function

    Binds to the C-terminal propeptide of types I and II procollagens and may enhance the cleavage of that propeptide by BMP1.

  • Target Subcellular Location

    Secreted.

  • Target Tissue Specificity

    Highly expressed in the heart, trabecular meshwork, pituitary gland, bladder, mammary gland, trachea and placenta and weakly expressed in the brain. Expressed in cartilage.

  • Target Research Area

    Cell Biology

  • Target Synonyms

    2400001O18Rik; MGC187469; PCOC2_HUMAN; PCOLCE 2; Pcolce2; PCOLE 2; PCOLE2; PCPE 2; PCPE-2; PCPE2; Procollagen C endopeptidase enhancer 2; Procollagen C proteinase enhancer 2; Procollagen C-endopeptidase enhancer 2; Procollagen C-proteinase enhancer 2; Procollagen COOH terminal proteinase enhancer 2; Procollagen COOH-terminal proteinase enhancer 2

Inquire Recombinant Human Procollagen C-endopeptidase enhancer 2 (PCOLCE2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification